[
  {
    "date": "2023-12-30",
    "symbol": "DOMH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 2833000,
    "marketablesecuritiescurrent": 13547000,
    "depositsassetscurrent": 7687000,
    "prepaidexpenseandotherassetscurrent": 898000,
    "notesandloansreceivablenetcurrent": 3177000,
    "assetscurrent": 28142000,
    "propertyplantandequipmentnet": 344000,
    "notesandloansreceivablenetnoncurrent": 1129000,
    "longterminvestments": 24150000,
    "operatingleaserightofuseasset": 3335000,
    "securitydeposit": 458000,
    "assets": 57558000,
    "accountspayableandaccruedliabilitiescurrent": 1036000,
    "accruedemployeebenefitscurrent": 51000,
    "accruedsalescommissioncurrent": 77000,
    "operatingleaseliabilitycurrent": 421000,
    "otherliabilitiescurrent": 22000,
    "liabilitiescurrent": 1607000,
    "operatingleaseliabilitynoncurrent": 3028000,
    "liabilities": 4635000,
    "additionalpaidincapital": 262187000,
    "treasurystockvalue": 501000,
    "retainedearningsaccumulateddeficit": -208763000,
    "stockholdersequity": 52923000,
    "liabilitiesandstockholdersequity": 57558000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 50000000,
    "preferredstocksharesissued": 3825,
    "preferredstocksharesoutstanding": 3825,
    "preferredstockliquidationpreference": 0.0001,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 5995065,
    "commonstocksharesoutstanding": 5934917,
    "treasurystockcommonshares": 60148,
    "revenues": 2039000,
    "generalandadministrativeexpense": 23838000,
    "researchanddevelopmentexpense": 3000,
    "researchanddevelopmentlicenseacquired": -6000,
    "operatingexpenses": 23835000,
    "operatingincomeloss": -21796000,
    "otherincome": 36000,
    "investmentincomeinterest": 716000,
    "marketablesecuritiesunrealizedgainloss": 630000,
    "gainlossonsaleofnotesreceivable": -3248000,
    "fairvalueadjustmentofwarrants": -780000,
    "nonoperatingincomeexpense": -1086000,
    "netincomeloss": -22882000,
    "netincomelossavailabletocommonstockholdersbasic": -22882000,
    "earningspersharebasic": -4.38,
    "weightedaveragenumberofsharesoutstandingbasic": 5229477,
    "earningspersharediluted": -3.95,
    "weightedaveragenumberofdilutedsharesoutstanding": 5229477,
    "sharesoutstanding": 4659,
    "treasurystockvalueacquiredcostmethod": 939000,
    "stockrepurchasedduringperiodshares": 236630,
    "stockissuedduringperiodvaluesharebasedcompensation": 2977000,
    "stockissuedduringperiodsharessharebasedcompensationgross": 1179468,
    "cancellationofcommonstockshares": -25000,
    "treasurystockretiredparvaluemethodamount": 3760000,
    "stockrepurchasedandretiredduringperiodshares": 644499,
    "adjustmentstoadditionalpaidincapitalstocksplit": 26000000,
    "amortizationofrightofuseassets": 359000,
    "depreciation": 83000,
    "changeinfairvalueofshortterminvestment": 13000,
    "changeinfairvalueoflongterminvestment": -793000,
    "sharebasedcompensation": 2977000,
    "marketablesecuritiesrealizedgainlossexcludingotherthantemporaryimpairments": -1180000,
    "unrealizedgainlossoninvestments": 1049000,
    "gainslossesonextinguishmentofdebt": 36000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 406000,
    "increasedecreaseinprepaidacquisitioncost": -301000,
    "increasedecreaseindepositotherassets": 4137000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 376000,
    "increasedecreaseinaccruedsalaries": -1209000,
    "increasedecreaseinaccruedcommissions": 52000,
    "increasedecreaseinoperatingleaseliability": -88000,
    "increasedecreaseinothercurrentliabilities": -99000,
    "increasedecreaseinnotesreceivables": 122000,
    "netcashprovidedbyusedinoperatingactivities": -22232000,
    "paymentstoacquiremarketablesecurities": 34125000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 27574000,
    "paymentstoacquiretangibleassets": 427000,
    "acquisitionoffpsnetofcashacquiredandreceivableowedfromfps": 1112000,
    "proceedsfromcollectionofnotesreceivable": 1102000,
    "paymentstoemployeeforgivableloan": 107000,
    "purchaseofshort-termandlong-terminvestments": 75000,
    "netcashprovidedbyusedininvestingactivities": -7170000,
    "paymentsforpurchaseoftreasurystock": 939000,
    "netcashprovidedbyusedinfinancingactivities": -939000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -30341000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2833000,
    "interestpaid": 686000,
    "receivingsharesinexchangeofnotereceivableextension": 179000,
    "notereceivableprincipalandinterestreceivablereducedduetoreceivingshares": 143000,
    "stockissued1": 3112000,
    "lessdepositpreviouslytransferredinoctober2022tofps": 2000000,
    "incometaxespaid": 1112000,
    "accountingforwarrantstextblock": "Accountingfor Warrants",
    "depositswithclearingbrokerpolicytextblock": "Depositswith clearing broker",
    "recentlyadoptedaccountingstandardspolicytextblock": "Recentlyadopted accounting standards",
    "effectofnewaccountingpronouncementstobeadoptedinfutureperiodspolicytextblock": "Effectof new accounting pronouncements to be adopted in future periods",
    "scheduleofchangeinthefairvalueoftheshortterminvestmentstabletextblock": "Thechange in the fair value of the short-term investments for the year ended December 31, 2023, is summarized as follows: ($ in thousands):",
    "scheduleofoperatingleasecostweightedaveragetabletextblock": "Thefollowing tables summarize quantitative information about the Company’s operating leases, under the adoption of ASC 842:",
    "equitymethodinvestmentrealizedgainlossondisposal": 1180000,
    "investmentincomedividend": 762000,
    "interestincomeshortterminvestmentincreasedecrease": 13000,
    "derivativeliabilitymeasurementinput": 0.8,
    "investmentownedatcost": 2140000,
    "paymentstoacquireinvestments": 75000,
    "receivingsharesinexchangeofnotereceivableextensions": 179000,
    "changeinfairvalueoflongterminvestments": 793000,
    "debtinstrumentmaturitydate": "2024-12-02",
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "notesreceivablegross": 1006000,
    "interestreceivable": 58000,
    "notesreceivablefairvaluedisclosure": 1064000,
    "equitysecuritiesfvni": 13547000,
    "marketablesecurities": 13547000,
    "investmentownedatfairvalue": -13000,
    "collectionofprincipaloutstanding": -1000000,
    "unrealizedlossonnotereceivable": -3254000,
    "principlereducedduetoreceiving": -143000,
    "accruedinterestreceivable": 100000,
    "unrealizedgainonnotereceivable": 6000,
    "paymentstoacquireotherreceivables": 23000,
    "propertyplantandequipmentestimatedusefullive": "Shorter of the remaining lease term or estimated useful life",
    "propertyplantandequipmentgross": 50000,
    "propertyplantandequipmentusefullife": "P3Y",
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 83000,
    "operatingleaseliability": 3449000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "operatingleasecost": 668000,
    "operatingleaseexpense": 668000,
    "shorttermleasecost": 105000,
    "leasecost": 800000,
    "operatingleasepayments": 396000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2780000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 747000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 685000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 766000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 1160000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4728000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1279000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 444796,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 29.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 2.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1315777,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1187536,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 395714,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.42,
    "employeeoptionsgrantedweightedaverageremainingcontractuallifeinyears": "P9Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 5882,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 857,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 9719.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 420168,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 84929,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 15.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y9M18D",
    "underwritingincomeloss": 594000,
    "brokeragecommissionsrevenue": 1096000,
    "paymentsformergerrelatedcosts": 209000,
    "noninterestincomeother": 140000,
    "deferredfederalincometaxexpensebenefit": 3820000,
    "increasedecreaseinvaluationallowancefederal": 3820000,
    "deferredstateandlocalincometaxexpensebenefit": 3012000,
    "increaseinvaluationallowancestateandlocal": 3012000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.1536,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0054,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.0418,
    "effectiveincometaxratereconciliationdecreaseduetotrueupofstatenol": -0.0011,
    "effectiveincometaxratereconciliationdecreaseduetochangeinfederalnolandothertrueups": -0.0167,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2985,
    "deferredtaxassetsoperatinglosscarryforwards": 33124000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9754000,
    "deferredtaxassetstaxpatentsandlicenses": 8061000,
    "deferredtaxassetshedgingtransactions": 209000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1937000,
    "deferredtaxassetsliabilitiesnet": 1202000,
    "deferredtaxassetsinvestments": 2879000,
    "deferredtaxassetsgross": 57166000,
    "deferredtaxassetsvaluationallowance": 55946000,
    "deferredtaxassetsnet": 1220000,
    "deferredtaxliabilitydepreciation": 57000,
    "deferredtaxliabilitiesregulatoryassetsandliabilities": 1163000,
    "sellinggeneralandadministrativeexpense": 15750000,
    "researchanddevelopmentexpenses": 3000,
    "othernonoperatingincome": 36000,
    "gainlossonsaleofaccountsreceivable": -3248000,
    "otheroperatingincomeexpensenet": 229000,
    "equitymethodinvestmentownershippercentage": 0.8,
    "investmentcompanyfeepaidindirectly": 1400000,
    "stockholdersequityreversestocksplit": "OnJune 7, 2022, the Company effected a seventeen-for-one (17-for-1) reverse stock split of its class of common stock (the “ReverseStock Split”).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "moneymarketfundsatcarryingvalue": 6700000,
    "taxbenifitpercentage": 0.5,
    "debtinstrumentinterestrateeffectivepercentage": 0.8,
    "businesscombinationconsiderationtransferredother1": 1400000,
    "businesscombinationstepacquisitionequityinterestinacquireepercentage": 1,
    "cashacquiredfromacquisition": 3400000,
    "supplementaldeferredpurchaseprice": 1000,
    "businessacquisitioncostofacquiredentitytransactioncosts": 300000,
    "debtinstrumentconvertiblethresholdpercentageofstockpricetrigger": 0.08,
    "debtinstrumentfaceamount": 1800000,
    "investmentmaturitydate": "2023-01-29",
    "depositliabilitiesaccruedinterest": 250000,
    "debtinstrumentrepaidprincipal": 1000000,
    "repaymentofinterestreceivable": 300000,
    "interestincomereceivable": 400000,
    "debtsecuritiesunrealizedgainloss": 3300000,
    "interestincomeother": 89000,
    "increasedecreaseinprepaidrent": 13502,
    "lesseeoperatingleaseremainingleaseterm": "P5Y",
    "restrictedcashandinvestments": 21000000,
    "aggregatecashfeepercentage": 0.08,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 103528,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 21.25,
    "debtinstrumentredemptionpricepercentage": 1.05,
    "stockrepurchaseprogramnumberofsharesauthorizedtoberepurchased": 236630,
    "stockrepurchaseprogramremainingauthorizedrepurchaseamount1": 900000,
    "saleofstockpricepershare": 3.97,
    "convertiblepreferredstocktermsofconversion": "convertible into 10 over 1,373 of a share of Common Stock.",
    "businessacquisitionpercentageofvotinginterestsacquired": 0.5,
    "sharesissued": 136309,
    "restrictedstockexpense": 2700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 200000,
    "allocatedsharebasedcompensationexpense": 200000,
    "allocatedsharebasedcompensationexpensenetoftax": 500000,
    "valuationallowancedeferredtaxassetchangeinamount": 6800000,
    "deferredtaxassetsnetoperatinglosscarryforwardsfederal": 40700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 152300000,
    "deferredtaxassetstaxcreditcarryforwardsother": 200000,
    "effectiveincometaxratereconciliationtaxcreditsinvestment": 0.5,
    "capitalunitsnetamount": 4900000,
    "excesscapital": 4700000,
    "relatedpartytransactionamountsoftransaction": 75000,
    "numberofreportablesegments": 2,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "DOMINARI HOLDINGS INC.",
    "entitycentralindexkey": 12239,
    "entityfilenumber": "001-41845",
    "entitytaxidentificationnumber": "52-0849320",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressaddressline1": "725 5th Avenue",
    "entityaddressaddressline2": "22nd Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10022,
    "cityareacode": "(212)",
    "localphonenumber": "393-4540",
    "security12btitle": "Common Stock ($0.0001 par value per share)",
    "tradingsymbol": "DOMH",
    "securityexchangename": "NASDAQ",
    "auditorname": "Marcum llp",
    "auditorfirmid": 688,
    "auditorlocation": "New York, NY"
  },
  {
    "date": "2021-12-31",
    "symbol": "DOMH",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 65562000,
    "marketablesecuritycurrent": 11427000,
    "prepaidexpenseandotherassetscurrent": 442000,
    "shortterminvestments": 418000,
    "notesreceivablerelatedpartiescurrent": 6984000,
    "depositsassetscurrent": 4201000,
    "assetscurrent": 90889000,
    "notesreceivablerelatedpartiesnoncurrent": 2147000,
    "investments": 9465000,
    "securitydeposit": 155000,
    "assets": 102656000,
    "accountspayableandaccruedliabilitiescurrent": 381000,
    "employeerelatedliabilitiescurrent": 680000,
    "liabilitiescurrent": 1061000,
    "liabilities": 1061000,
    "commonstockvalue": 9000,
    "additionalpaidincapital": 265624000,
    "treasurystockvalue": 264000,
    "retainedearningsaccumulateddeficit": -163774000,
    "stockholdersequity": -163774000,
    "liabilitiesandstockholdersequity": 102656000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 5000000,
    "preferredstocksharesissued": 834,
    "preferredstocksharesoutstanding": 834,
    "preferredstockliquidationpreference": 0.0001,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 89681258,
    "commonstocksharesoutstanding": 89681255,
    "sellinggeneralandadministrativeexpense": 7734000,
    "researchanddevelopmentexpense": 559000,
    "researchanddevelopmentlicenseacquired": 1148000,
    "operatingexpenses": 9441000,
    "operatingincomeloss": -9441000,
    "otherincome": 135000,
    "interestincomeexpensenet": 252000,
    "marketablesecuritiesgainloss": -1743000,
    "gainlossoninvestments": 3626000,
    "othernonoperatingincomeexpense": 2270000,
    "netincomeloss": -7171000,
    "earningspersharebasicanddiluted": -0.09,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 82398369,
    "sharesoutstanding": 3,
    "stockissuedduringperiodvalueofcommonstockandwarrants": 78219000,
    "stockissuedduringperiodsharesofcommonstockandwarrants": 53905927,
    "stockissuedduringperiodvaluestockoptionsexercised": 84000,
    "stockissuedduringperiodsharesstockoptionsexercised": 80000,
    "stockissuedduringperiodvalueissuedforresearchanddevelopmentlicenseacquired": 531000,
    "stockissuedduringperiodsharesissuedforservices": 625000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -900,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationotherlongtermincentiveplansrequisiteserviceperiodrecognition": 314000,
    "stockissuedduringperiodsharessharebasedcompensation": 150000,
    "profitloss": -7171000,
    "warrantnetofferingcosts": 8031000,
    "changeinfairvalueofinvestments": -3626000,
    "researchanddevelopmentacquiredlicenseexpensed": 1148000,
    "sharebasedcompensation": 314000,
    "marketablesecuritiesrealizedgainloss": -67000,
    "marketablesecuritiesunrealizedgainloss": -3115000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 227000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -186000,
    "increasedecreaseinaccruedsalaries": 370000,
    "increasedecreaseinnotesreceivables": 252000,
    "increasedecreaseinsecuritydeposits": -155000,
    "netcashprovidedbyusedinoperatingactivities": -6603000,
    "purchaseofmarketablesecurities": 93432000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 103043000,
    "proceedsfromsaleofdatchatcommonshares": 900000,
    "fundstodepositaccounts": 4201000,
    "paymentstoacquireinvestments": 5666000,
    "unpaidinvestment": -617000,
    "repaymentofconvertibledebt": 2000000,
    "paymentstoacquireshortterminvestments": 6880000,
    "netcashprovidedbyusedininvestingactivities": -8853000,
    "proceedsfromissuancecommonstockandwarrantsnetofofferingcost": 78219000,
    "proceedsfromwarrantexercises": 84000,
    "netcashprovidedbyusedinfinancingactivities": 78303000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 62847000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 65562000,
    "goingconcernandfinancialconditiontextblock": "Note 2. Liquidity and Capital Resources ",
    "licenseagreementwithothercompaniestextblock": "Note 4. License agreement with Silo PharmaInc. ",
    "shortterminvestmentinvestmentindatchatinctextblock": "Note 6. Short-term investments  ",
    "accountingforwarrantspolicytextblock": "Accounting for Warrants ",
    "depositspolicytextblock": "Deposits ",
    "scheduleofshortterminvestmentstabletextblock": "            As of December 31,             2021      2020       Investment in Hoth Therapeutics, Inc.     $770      $            -       Investment in DatChat, Inc.      1,084       -       Investment in Vicinity Motor Corp.      418       -       Total     $2,273      $-    ",
    "scheduleofinvestmentindatchattabletextblock": "      Security Name     Shares Owned as    of  December 31, 2021      Fair value per Share as of December 31, 2021      Fair value as ofDecember 31,  2021 (in thousands)       DATS      357,916      $3.03      $1,084    ",
    "scheduleofquantitativeinformationfairvaluemeasurementsinputstextblock": "            As of Octorber 25, 2021      As of December 31, 2021       Option term (in years)              3.0               2.8       Volatility      94.10%      95.52%      Risk-free interest rate      0.76%      0.97%      Expected dividends      0.00%      0.00%      Stock price     $4.11      $3.50   ",
    "dividendincomeoperating": 1439000,
    "marketablesecuritiesgainlosses": -1743000,
    "investmentownedbalanceshares": 357916,
    "shareprice": 3.03,
    "investmentownedatfairvalue": 1084000,
    "quantitativeinformationfairvaluemeasurementoptionterm": 2.8,
    "quantitativeinformationfairvaluemeasurementsvolatility": 0.9551999999999999,
    "quantitativeinformationfairvaluemeasurementsriskfreeinterestrate": 0.0097,
    "quantitativeinformationfairvaluemeasurementsstockprice": 3.5,
    "otherlongterminvestments": 9465000,
    "debtinstrumentmaturitydate1": "01/29/2023",
    "debtinstrumentinterestratestatedpercentage": 0.08,
    "debtinstrumentunamortizeddiscount": 147000,
    "financialliabilitiesfairvaluedisclosure": 2147000,
    "equitysecuritiesfvni": 11427000,
    "marketablesecuritiescurrent": 11427000,
    "notesreceivableatfairvalue": 6984000,
    "receivablesfairvaluedisclosure": 2147000,
    "fairvalueadjustmentofwarrants": 418000,
    "shortterminvestmentendingbalance": 418000,
    "purchaseofnotesreceivable": 6880000,
    "accruedliabilitiescurrentandnoncurrent": 105000,
    "notesreceivableatfairvalueendingbalance": 6984000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasiswithunobservableinputs": 2147000,
    "convertiblenotereceivablepurchaseofnotesreceivable": 2000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitytransfersnet": 147000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6281932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberofwarrant": 5801701,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms1": 3.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsissued": 4312473,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalueissued": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 4.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": -80000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalueexcercised": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 4650,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageintrinsicvalue": 19.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitedwarrantsforfeitedwarrants": -3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexercisepriceofwarrants": 16.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.2409999999999999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0045000000000000005,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 479654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 32.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm3": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 479654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 32.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 100000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": 9.1,
    "deferredfederalincometaxexpensebenefit": -1581000,
    "increasedecreaseinvaluationallowancefederal": 1581000,
    "deferredstateandlocalincometaxexpensebenefit": 2492000,
    "increasedecreaseinvaluationallowancestate": -2492000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0087,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": -0.0565,
    "decreaseduetotrueupofstatenol": -0.4495,
    "decreaseduetochangeinfederalnolandothertrueups": 0.12960000000000002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.1751,
    "deferredtaxassetsoperatinglosscarryforwards": 20161000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8196000,
    "deferredtaxassetsgoodwillandintangibleassets": 13917000,
    "deferredtaxassetsgross": 42274000,
    "deferredtaxassetsvaluationallowance": 39759000,
    "deferredtaxassetsnet": 2516000,
    "deferredtaxassetsliabilitiesnet": 2516000,
    "descriptionofbiotechnologyresearchdevelopment": "Preclinical studies have also indicated that DHA-dFdC inhibits pancreatic cancer cell growth (up to 100,000-fold more potent thatgemcitabine, a current standard therapy), targets pancreatic tumors and has demonstrated activities against other cancers, includingleukemia, lung and melanoma.",
    "sharesissued": 1379685,
    "paymentsforunderwritingexpense": 78000000,
    "custodyfees": 800000,
    "heldincash": 4200000,
    "investmentsinmarketablesecurities": 70000,
    "saleofstockpricepershare": 0.2,
    "fairvalueofwarrant": 400000,
    "investmentsfairvaluedisclosure": 400000,
    "otherinvestments": 1000000,
    "unrealizedgainlossonderivatives": 1000000,
    "debtinstrumentfeeamount": 2000000,
    "interestreceivablenoncurrent": 1000,
    "assetsfairvalueadjustment": 800000,
    "classofwarrantorrightforissuingtoconsultant": "TheCompany also issued placement agent warrants to the placement agent (the “Placement Agent Warrant”) to purchase 1,120,000shares of common stock with an exercise price of $1.25 per share. ",
    "saleofstocknumberofsharesissuedintransaction": 4312473,
    "percentageofstocksold": 0.08,
    "exercisableyears": "five years",
    "votingpowerpercentage": 0.5,
    "optionsoutstanding": 479654,
    "sharegrant": 4520346,
    "stockissuedduringperiodvaluesharebasedcompensation": 200000,
    "stockissuedduringperiodvalueofcommonstockforresearchanddevelopmentlicensesacquired": 500000,
    "valuationallowancedeferredtaxassetchangeinamount": 4099999.9999999995,
    "incometaxexaminationdescription": "The Company filed Form 1139 in 2020 and received a cash refund for its $85k AMT credit carry forward beforeDecember 31, 2020.",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": 41000000,
    "deferredtaxassetsoperatinglosscarryforwardsfederal": 22000000,
    "descriptionofoperatinglosscarryforwardsexpiration": "The Company has approximately $85 million of stateand city NOLs, which expire from 2024 through 2040.",
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 85000000,
    "percentageofownership": 0.5,
    "ultimatesettlement": 0.5,
    "administrativefeesexpense": 1200000,
    "entityregistrantname": "AIkido Pharma Inc.",
    "tradingsymbol": "AIKI",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 12239,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-05576",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "52-0849320",
    "entityaddressaddressline1": "OneRockefeller Plaza,",
    "entityaddressaddressline2": "11th Floor,",
    "entityaddresscityortown": "New York,",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10020,
    "cityareacode": 703,
    "localphonenumber": "992-9325",
    "security12btitle": "Common Stock ($0.0001 par value per share)",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Marcum llp",
    "auditorlocation": "New York, NY",
    "auditorfirmid": 688
  }
]